PMSA 2014: Where is the industry headed?

,
As I think back about the Pharmaceutical Management Science Association annual conference (held in May), I am continually impressed with how the group developed such a cutting edge agenda of where we, as industry commercial analysts, are going.…

PMSA 2014 Conference - Verix is All the Buzz

,
It was a great show for Verix at the PMSA 2014 Conference in Orlando, Florida, as 300+ influential minds from the pharmaceutical commercial operations industry such as Pfizer, Eli Lilly & Company, Bayer, and Janssen Pharmaceutical, Inc.…

PGHD: the Next Wave in Pharma Data?

Lately, I’ve been writing a lot about Big Data, electronic health records, the ACA and their impact on the pharmaceutical industry.  While these influences are definitely directly “in our windshield,” (particularly with Meaningful Use…

15 Fatal Errors in Pharma Analytics

,
Data is critical to any business operation. It provides the information that enables the commercial operations team to make informed business decisions. Setting up pharma analytics may sound as simple as buying a reporting a tool, but experience…

Meet Verix at PMSA 2014

,
In less than two weeks time on May 18th, Verix will be rolling into Orlando to take the 2014 Pharmaceutical Management Science Association Annual Conference by storm as a GOLD SPONSOR. This event’s tagline fits perfectly with our professional…

Is there a better way to launch a drug?

,
Oftentimes in launches, physicians are deciled in the traditional way (via TRxs).  Call plans, messaging and promotional efforts are developed based upon this segmentation.  These high prescribers are often believed to be the most valuable…

The Shift to Specialty Drugs and its Commercial Implications

,
With the continued focus on value and outcomes in today’s new pharmaceutical world, many companies are changing their R&D strategy away from mass-produced, PCP drugs towards specialty drugs that treat chronic, serious or life-threatening…

6 Critical Questions Worth Asking to Master Data in Specialty Pharma

,
Selling drugs through specialty pharmacies (SPs) presents many opportunities and challenges to pharmaceutical companies. On the one hand, oftentimes the data received from each SP can be very rich. On the other hand, setting up these protocols…

Analytics and Influence – The Importance of Why

, , ,
As a management consultant, I was taught to use the technique of the “Five Whys” to get to the root cause of my client’s issue. Oftentimes, what people first say doesn’t exactly get to the heart of the matter. The idea behind the practice…

Can Pharma support the Accountable Care Model?

The CEO of Starbucks once quipped that the company spends more on healthcare than it does on coffee beans. If this statistic is real or not, we can’t attest. But the reaction of most that hear this is “well, that makes sense.” Health care…